论文部分内容阅读
目的:探讨分析布地奈德联合沙丁胺醇雾化吸入治疗支气管哮喘临床疗效。方法:选取该院自2014年6月至2015年6月这段时期内收治的80例支气管哮喘患者作为研究对象,将其随机分成研究组和对照组各40例,两组患者均给予常规治疗,同时在此基础上给予研究组的患者采用布地奈德联合沙丁胺醇雾化吸入治疗,给予对照组的患者单纯采用沙丁胺醇雾化吸入治疗,观察两组患者的临床疗效并进行比较。结果:研究组患者的总治疗有效率为95.0%,对照组患者的总治疗有效率为77.5%,研究组患者的总治疗有效率明显比对照组患者高(P<0.05)。结论:采用布地奈德联合沙丁胺醇雾化吸入治疗支气管哮喘可明显缓解患者症状,有助于提高临床疗效,非常值得在临床上推广。
Objective: To investigate the clinical efficacy of budesonide combined with salbutamol inhalation in the treatment of bronchial asthma. Methods: Eighty patients with bronchial asthma admitted from June 2014 to June 2015 in our hospital were enrolled in this study. They were randomly divided into study group (40 cases) and control group (40 cases). Both groups were given routine treatment At the same time, the patients in the study group were treated with inhalation of budesonide combined with salbutamol inhalation. Patients in the control group were treated with salbutamol inhalation alone. The clinical efficacy and the comparison of the two groups were observed. Results: The total effective rate was 95.0% in the study group and 77.5% in the control group. The total effective rate of the study group was significantly higher than that of the control group (P <0.05). Conclusion: The use of budesonide combined with salbutamol nebulization in the treatment of bronchial asthma can significantly alleviate the symptoms of patients and help to improve the clinical curative effect, which is worth to be popularized clinically.